Resectability classification in pancreatic cancer in the 7th Edition of General Rules for the Study of Pancreatic Cancer by the Japan Pancreas Society-Reference-Cited by-同舟云学术

Resectability classification in pancreatic cancer in the 7th Edition of General Rules for the Study of Pancreatic Cancer by the Japan Pancreas Society

Published:2016 Issue:6 Volume:31 Page:799-804
ISSN:0913-0071
Container-title:Suizo
language:en
Short-container-title:Journal of the Japan Pancreas Society

Author:

KITAGAWA Hirohisa¹

Affiliation:

1. Department of Gastroenterologic Surgery, Toyama City Hospital

Publisher

Japan Pancreas Society

Link

https://www.jstage.jst.go.jp/article/suizo/31/6/31_799/_pdf

Reference8 articles.

1. 1) Mochizuki K, Gabata T, Kozaka K, et al. MDCT findings of extrapancreatic nerve plexus invasion by pancreas head carcinoma: correlation with en bloc pathological specimens and diagnostic accuracy. Eur Radiol 2010; 20: 1757-67.

2. 3) Katz MH, Marsh R, Herman JM, et al. Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design. Ann Surg Oncol 2013; 20: 2787-95.

3. 4) Network NCC. NCCN clinical practice guidelines in oncology. Pancreatic adenocarcinoma, version 2. 2016 edn. 2016.

4. 5) Kato H, Usui M, Isaji S, et al. Clinical features and treatment outcome of borderline resectable pancreatic head/body cancer: a multi-institutional survey by the Japanese Society of Pancreatic Surgery. J Hepatobiliary Pancreat Sci 2013; 20: 601-10.

5. 6) Kitagawa H, Tajima H, Nakagawara H, et al. En bloc vascular resection for the treatment of borderline resectable pancreatic head carcinoma. Mol Clin Oncol 2014; 2: 369-74.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gemcitabine+nab-paclitaxel併用術前化学療法によりpathological complete responseが得られ根治的切除が可能であった下大静脈浸潤を伴う膵頭部癌の1例;The Japanese Journal of Gastroenterological Surgery;2023-03-01